Partnering & Outsourcing Editorial

  1. Trip Or No Trip: Pharmas Are Taking Psychedelic Trials To Australia 12/13/2023

    Enveric Biosciences CEO Joseph Tucker, Ph.D., chronicles the company's quest for regulatory approval in Australia, as well as navigates the unknowns of developing psychedelics for therapeutic use.

  2. Outsourcing And Phase-Appropriate GMP For Clinical Manufacturing Needs 11/20/2023

    Appropriate manufacturing and timely delivery of investigational products are essential for the successful execution of clinical trials. This article shares best practices working with CDMOs as well as phase-appropriate GMP of the clinical supply.

  3. In Search Of The Unicorn: Do End-To-End C(x)DMOs Really Exist? 11/8/2023

    Over the years, we have seen the progression of the biologics contract services go from contract manufacturing organizations (CMO) to what this expert today calls the C(x)DMO: the contract analytical/research/testing development manufacturing organization. Focusing on the mammalian biologics segment, this expert analyzed public information and a proprietary database by looking at 80 service providers supporting projects ranging from early discovery to commercial manufacturing. 

  4. Identifying & Enabling Innovative Partnerships With Reeve Foundation CEO Maggie Goldberg 10/16/2023

    CEO Maggie Goldberg discusses the Reeve Foundation’s partnership approach — from how partners are identified to what each sector brings to the field of SCI to how partnerships are evaluated for effectiveness.

  5. The One Soft Skill That Many CRPs Are Missing 9/29/2023

    Employee burnout appears rampant across industries, and clinical research is not immune. So, what's a pharma, CRO, or site to do? Aga Finlayson of White Wisteria Academy has an idea: honing one specific clinical research professional soft skill to the benefit of employers and employees alike.

  6. 4 Pitfalls Of Poor-Performing Clinical Trial Teams — And How To Prevent Them 9/25/2023

    Sudden teammate departure? Unexpected shift in strategy? Learn about the four common pitfalls (related to communications and team expectations) of clinical operations teams — and how to avoid them — with these pointers from consultant Monica Roy.

  7. Moving From Clinical Stage To Commercial? 4 Steps For An Outsourcing Strategy 9/18/2023

    If you're a pre-commercial bio/pharma looking ahead to commercial stage, evaluating partnerships are faced with making key decisions around which capabilities to outsource, the degree of data access and ownership, and which external partners are the right fit. Here are four key actions to consider.

  8. Cautious Optimism For Biotechs And Their Outsourcing Partners 9/5/2023

    Pre-revenue, including preclinical and clinical stage, biotechs have been the most impacted but also stand to gain the most after the economic downturn and subsequent recovery. This article will delve into how small to midsize pre-revenue biotechs have been specifically impacted and what this could mean for organizations that support them.

  9. Efficient Biotech Vendor Selection And Management During Economic Uncertainty 8/30/2023

    To navigate these turbulent economic waters effectively, we must view this funding crunch as a push for creativity and resiliency. This present moment requires a strategy integrating savvy financial management and strategic vendor selection to ensure a thriving biotech.

  10. Assessing Specialized Services Provided By CROs 8/23/2023

    Once upon a time, a CRO's main role was to provide clinical trial site and data management. Now, CROs offer a wide range of services, from those that specialize in certain therapeutic areas to those that offer the latest technology. Here's a breakdown of the types of CROs and the services they offer.